Final Diagnosis: Infective Endocarditis Due to Granulicatella adiacens and Streptococcus mitis.
Toni Campanella, PharmD*
Advertisement
Articles by Toni Campanella, PharmD*
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.
Advertisement
Latest Updated Articles
- Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back Again
February 13th 2020
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves Ensitrelvir as First Oral Post-Exposure Prevention Option for COVID-19
2
Migration Trends Demonstrate Rare, But Increasing Malaria Cases in New York City
3
PolyPid Completes FDA NDA Submission for D-PLEX100 in Surgical Site Infection Prevention
4
Post-Exposure Protocol for STDs Prompts Resistant Gonorrhea
5